Literature DB >> 30038352

Relationship between clostridium difficile infection and gastrointestinal graft versus host disease in recipients of allogeneic stem cell transplantation.

Divaya Bhutani1, Charles Jaiyeoba2, Seongho Kim3, Paul Naylor2, Joseph P Uberti3, Voravit Ratanatharathorn3, Lois Ayash3, Abhinav Deol3, Asif Alavi3, Sanjay Revankar3,4, Pranatharthi Chandrasekar3,4.   

Abstract

Entities:  

Year:  2018        PMID： 30038352      PMCID： PMC6844071          DOI： 10.1038/s41409-018-0270-x

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  11 in total

1.  Recent epidemiology of Clostridium difficile infection during hematopoietic stem cell transplantation.

Authors:  Teena Chopra; Pranatharthi Chandrasekar; Hossein Salimnia; Lance K Heilbrun; Daryn Smith; George J Alangaden
Journal:  Clin Transplant       Date:  2010-10-25       Impact factor: 2.863

2.  Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea.

Authors:  Vijay C Antharam; Eric C Li; Arif Ishmael; Anuj Sharma; Volker Mai; Kenneth H Rand; Gary P Wang
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

3.  Clostridium difficile infection in the hematopoietic unit: a meta-analysis of published studies.

Authors:  Ioannis M Zacharioudakis; Panayiotis D Ziakas; Eleftherios Mylonakis
Journal:  Biol Blood Marrow Transplant       Date:  2014-06-07       Impact factor: 5.742

4.  Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

Authors:  A Bacigalupo; T Lamparelli; P Bruzzi; S Guidi; P E Alessandrino; P di Bartolomeo; R Oneto; B Bruno; M Barbanti; N Sacchi; M T Van Lint; A Bosi
Journal:  Blood       Date:  2001-11-15       Impact factor: 22.113

5.  Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients.

Authors:  Carolyn D Alonso; Suzanne B Treadway; David B Hanna; Carol Ann Huff; Dionissios Neofytos; Karen C Carroll; Kieren A Marr
Journal:  Clin Infect Dis       Date:  2012-03-12       Impact factor: 9.079

6.  Relative incidences and outcomes of Clostridium difficile infection following transplantation of unrelated cord blood, unrelated bone marrow, and related peripheral blood in adult patients: a single institute study.

Authors:  K Hosokawa; A Takami; M Tsuji; H Araoka; K Ishiwata; S Takagi; H Yamamoto; Y Asano-Mori; N Matsuno; N Uchida; K Masuoka; A Wake; S Makino; A Yoneyama; S Nakao; S Taniguchi
Journal:  Transpl Infect Dis       Date:  2014-05-09       Impact factor: 2.228

Review 7.  The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.

Authors:  Anna Staffas; Marina Burgos da Silva; Marcel R M van den Brink
Journal:  Blood       Date:  2016-12-09       Impact factor: 22.113

Review 8.  Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management.

Authors:  Daniel Couriel; Humberto Caldera; Richard Champlin; Krishna Komanduri
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

9.  Low-dose antithymocyte globulin enhanced the efficacy of tacrolimus and mycophenolate for GVHD prophylaxis in recipients of unrelated SCT.

Authors:  V Ratanatharathorn; A Deol; L Ayash; S Cronin; D Bhutani; L G Lum; M Abidi; M Ventimiglia; K Mellert; J P Uberti
Journal:  Bone Marrow Transplant       Date:  2014-10-06       Impact factor: 5.483

Review 10.  Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond.

Authors:  M Mohty
Journal:  Leukemia       Date:  2007-04-05       Impact factor: 11.528
View more
  1 in total

1.  Prevalence of Clostridium difficile Infection in the Hematopoietic Transplantation Setting: Update of Systematic Review and Meta-Analysis.

Authors:  Ying Luo; Sumei Zhang; Hua Shang; Weitong Cui; Qinglu Wang; Bin Zhu
Journal:  Front Cell Infect Microbiol       Date:  2022-02-21       Impact factor: 5.293
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.